Swisse Wellness Pty Ltd   Report issue

For profit Phase 2 Phase 3
Founded: Melbourne Australia (1969)
Status: No NME R&D (1969)

Organization Overview

First Clinical Trial
2017
NCT03042273
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Swisse Wellness Pty Ltd

Active Ingredients

Drugs in Phase 3 Trials (1)

b multivitamins (1 trial)

Drugs in Phase 2 Trials (1)

krill oil (1 trial)

Drugs in Other Trials (1)

cranberry (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3